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Abstract Extracorporeal shock wave lithotripsy (ESWL),
percutaneous nephrolithotomy (PCNL) and ureteroscopy
(URS) currently represent the mainstay treatment options for
the vast majority of patients with urolithiasis, with limited
contraindications and high success rates. However, minimally
invasive extracorporeal and endourological treatments are
associated with a non-negligible morbidity including occa-
sional life-threatening occurrences. These complications rep-
resent a source of concern for urologists since they may result
in prolonged hospitalisation, need for surgical, endoscopic or
interventional treatment, long-term renal impairment, and
sometimes even medical malpractice claims. Due to the in-
creasing prevalence of urolithiasis and the large number of
therapeutic procedures performed, in hospitals with active
urologic practices radiologists are increasingly requested to
investigate suspected post-procedural complications follow-
ing ESWL, PCNL or ureteroscopic stone removal. Based
upon our experience, this pictorial essay provides an overview
of current extracorporeal and endourological treatment mo-
dalities for urolithiasis, including indications and possible
complications according to the most recent guidelines from
the European Association of Urology (EAU). Afterwards, we
review the clinical features and cross-sectional imaging ap-
pearances of common and unusual complications with case
examples, including steinstrasse, subcapsular, perirenal and
suburothelial haemorrhages, severe urinary tract infections
(such as pyeloureteritis, pyelonephritis, renal abscesses and
pyonephrosis), ureteral injuries and delayed strictures.
Teaching points
• Extracorporeal lithotripsy, percutaneous nephrolitotomy
and ureteroscopy allow treating urolithiasis.
• Minimally invasive extracorporeal and endourological
treatment have non-negligible morbidity.
• Multidetector CT allows confident assessment of stone-free
status and postprocedural complications.
• Main complications include steinstrasse, bleeding, severe
infections, ureteral injuries and strictures.
• Imaging triage allows the choice among conservative, sur-
gical, endoscopic or interventive treatment.
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Introduction
Background
Urolithiasis represents one of the most common urogenital
disorders and occurs in approximately 4–5 % of the general
population in European countries. In the USA, the lifetime
risk of symptomatic kidney stones has been estimated to
approximate 13 % in men and 7 % in women, leading to
substantial cost in terms of emergency department visits,
use of imaging and treatment. The increasing prevalence
and incidence of urolithiasis reported over the last decades
probably results from the combined effects of nutritional
changes, environmental factors and improved diagnosis,
particularly with the extensive use of unenhanced multide-
tector CT (MDCT) [1, 2].
During the last 30 years, modern extracorporeal and
endourological therapies have revolutionised the field of
urology and dramatically reduced the number of surgical
procedures, which are now second- or third-line treatment
options reserved for only 1–1.5 % of patients. Extracor-
poreal shock wave lithotripsy (ESWL), percutaneous
nephrolithotomy (PCNL) and retrograde ureteroscopy
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(URS) currently represent the established treatment for the
vast majority of urolithiasis cases needing active stone
removal [3, 4].
However, despite increasing operator experience and
technical advancements including refined energy applica-
tions and endourological equipment, minimally invasive
therapies for urolithiasis are associated with a non-
negligible morbidity. Iatrogenic complications represent
a source of concern for urologists since they may require
prolonged hospitalisation and additional surgical, endo-
scopic or interventional treatment, may have detrimental
effects on renal function and sometimes even lead to
medical malpractice claims [4–6].
Aim
Most previous reports in the radiological literature mainly
focussed on imaging complications after nephrostomy and
ureteral stenting using conventional radiographic techniques
such as plain radiographs and trans-nephrostomy pyelography
[7, 8].
Although improved techniques, experience and instrumen-
tation have led to a decreasing incidence of urologic iatrogenic
injuries during the past decade, due to the large number of
urological procedures performed, radiologists are increas-
ingly requested to investigate suspected early or delayed
complications following ESWL, PCNL or ureteroscopic
stone removal [5]. Based upon our experience, this article
discusses the fundamentals and indications of minimally
invasive treatment options for urolithiasis, then reviews
and illustrates the clinical features and cross-sectional im-
aging appearances of common and unusual complications
with emphasis on MDCT, aiming to provide radiologists
with an increased familiarity with post-procedural imaging
in patients being treated for urolithiasis.
Minimally invasive treatment of urolithiasis
Overview and indications
According to the most recent guidelines from the European
Association of Urology (EAU), the main indications for active
removal of renal calculi include stone growth, obstruction,
associated infection, renal insufficiency, and acute and/or
chronic pain. Nowadays, open or laparoscopic surgery is
reserved for the few patients with complex stone burden after
failure of ESWL or endourological procedures, morbid obe-
sity, anatomical abnormalities (such as renal ectopia) not
amenable to other therapies and non-functioning kidneys re-
quiring nephrectomy [4].
Currently, there is a consensus that most complex (includ-
ing partial and complete staghorn) stones should be primarily
approached by means of PCNL. ESWL represents the pre-
ferred initial approach for pelvic, upper or mid-calyceal calculi
up to 2 cm in size as well as for sub-centimetre distal ureteral
stones including those at the vesico-ureteral junction. Con-
versely, due to the limited efficacy of ESWL, endourological
procedures such as PCNL and retrograde intrarenal surgery
(RIRS) are recommended for large (>2 cm), shockwave-
resistant (such as those containing calcium oxalate) or lower
pole renal stones. Finally, URS represents the ideal modality
for both multiple or single ureteral stones above 1 cm [4].
Extracorporeal shock wave lithotripsy
Since its introduction in the early 1980s, ESWL has dramat-
ically changed the management of urolithiasis and is currently
accepted as the preferred and least invasive first-line treatment
for the majority (almost 90 %) of patients with renal and
ureteral calculi without spontaneous passage. During the last
30 years, its use has become widespread, and millions of
treatments have been performed worldwide. Its limited con-
traindications including pregnancy, coagulation disorders, car-
diac arrhythmias, uncontrolled urinary infection, renal failure,
anatomic urinary tract abnormalities or obstruction distal to
the stone, severe skeletal deformity and obesity, and proximity
to an arterial aneurysm [4, 9, 10].
During ESWL, shock waves generated outside the body
cross through the soft tissues without loss of strength and
cause disintegration of urinary stones into smaller portions
through direct shearing force, erosion or cavitation. With the
increasing availability of newer and improved lithotripters, the
patient tolerance and efficacy of the procedure have increased;
therefore, ESWL is usually performed in an outpatient setting
without general anaesthesia and can be repeated as necessary.
Routine pre-treatment stenting has now been abandoned be-
cause it contributes minimally to the prophylaxis of compli-
cations and may reduce the stone-free rate (SFR). ESWL
achieves a 78–82 % overall success rate (SFR at 3 months)
with a significant (45–53%) proportion of repeated treatments
and 8.4–11 % need for auxiliary procedures [4, 9–14].
Although it may seem a noninvasivemodality, ESWL has a
reported 15.3% overall complications rate, which is inferior to
that occurring after PCNL and URS. The most common
occurrences include cardiac dysrhythmia (11–5 %), bacteri-
uria (7.7–23 %), bleeding (4–19 %), steinstrasse (3.6–7 %),
renal colic (2–4 %) and urosepsis (1–2.7 %) in descending
order of frequency, plus sporadic severe cardiovascular
events, bowel perforations, liver or spleen haematomas. How-
ever, major post-ESWL complications are very uncommon
compared to the vast number of procedures performed world-
wide and include mostly steinstrasse, severe haemorrhage and
urosepsis [4, 13, 14].
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Although the mechanism underlying haemorrhage in-
volves the compressive and tensile force of the shock
waves on the soft tissues coupled with the cavitation
effect on cell integrity, no clear correlation exists with
the number and intensity of applied shock waves. Pre-
disposing factors include hypertension, diabetes, obesity,
advanced age, coagulation deficits and use of antiplate-
let medications. Symptomatic or clinically significant
bleeding requiring blood replacement occurs in approx-
imately 2 out of 1,000 treated patients. Similarly, a
large multicentre study assessed the incidence of renal
haematomas at 0.5 and 0.14 % following ESWL treat-
ment of renal and ureteral stones respectively [4, 9–11,
13–16]. Retroperitoneal haemorrhage after ESWL may
cause haemodynamic shock and occasionally be fatal
[17, 18].
Percutaneous nephrolithotomy
Currently considered the standard procedure for large renal
calculi, PCNL is increasingly performedwithout nephrostomy
or ureteral stenting and with the use of ultrasound, pneumatic
and Ho:YAG laser devices as well as forceps or nitinol baskets
for stone extraction. Contraindications include untreated
infections, pregnancy, atypical bowel interposition, and
known or suspected kidney tumour. Compared to
ESWL, PCNL achieves stone-free status in 95 and
85 % of cases at 1 week and 3 months, respectively,
without the need for repeated procedures in the vast
majority of cases [4, 19].
Although most patients experience an uneventful postop-
erative course, percutaneous treatment of urolithiasis is asso-
ciated with 20–29 % overall and 4–5.2 % severe complication
rates, and occasional fatalities. High-risk patients include
those with anatomical abnormalities, large or staghorn stones,
and comorbidities, such as diabetes, and those requiring upper
pole or multisite access. Pre-existent urine infection and ab-
sent hydronephrosis represent risk factors for sepsis and se-
vere bleeding, respectively. Following PCNL the most com-
mon adverse events include fever (10–23 %) and urinary
infection, respiratory impairment (due to pneumothorax, pleu-
ral effusion, atelectasis or pneumonia), ileus, bleeding,
urosepsis (0.5 % of patients), renal pelvis laceration and
ureteral stricture, in descending order of frequency, plus spo-
radic cases of visceral injuries to the spleen and large bowel.
Surgical or interventional treatment is required in up to one-
third of all complications [4, 5, 20–27].
One of the most common and worrisome PCNL-related
complications, haemorrhage, occurs in variable entities after
nearly one-third of procedures. Perioperative bleeding requir-
ing blood transfusions and/or operative treatment is reported
in 3.8–11 % of cases, particularly in patients with comorbid-
ities, advanced age, staghorn calculi and prolonged operative
time. After PCNL bleeding may be venous, acute (from injury
to the anterior or posterior segmental arteries) or delayed (due
to interlobar and lower-pole arterial lesions, arterio-venous
fistula or post-traumatic aneurysm) [5, 20, 21, 23, 25, 27, 28].
Ureteroscopic stone removal
URS represents an established minimally invasive treatment
with a high success rate and acceptable morbidity, which has
dramatically improved the outcome of patients with ureteral
calculi. Increasingly performed without routine ureteral
stenting, URS has recently undergone technical advances
including improved equipment, which allows RIRS,
intracorporeal lithotripsy using the Ho:YAG laser, and com-
plete stone removal using endoscopic forceps or nitinol bas-
kets. As a result, the expanded indications now range from
treatment of small distal ureter stones using a semirigid URS
to larger sized renal pelvis stones treated by a flexible URS [4,
29].
Compared to ESWL, URS offers a superior success rate
(approximately 90 %) at the expense of greater invasiveness
with increased morbidity and longer hospital stays. Reported
results include 81.9 %, 87.3 % and 94.9 % SFR for the
proximal, mid- and distal ureter respectively, a 7.75 %
retreatment rate and need for auxiliary procedures in 18.6 %
of cases [14, 30].
The majority of postoperative URS complications are mi-
nor occurrences such as haematuria and urinary infection. The
risk is further increased by preoperative bacteriuria,
hydronephrosis, longer operative time and limited hospital
experience. More significant occurrences include persistent
haematuria (2 % of cases), renal colic (2.2 %), urosepsis
(1.1 %) and bleeding (0.1 %). Furthermore, aggressive
ureteroscopic procedures such as RIRS currently represent
the leading cause of the reported increase in iatrogenic ureteral
injuries. Whereas mucosal damage is relatively common (41–
46 % of URS procedures), severe injury involving the mus-
cular layer or deeper may occur in up to 13–18 % of cases and
may be largely reduced by prophylactic stenting. Recognition
and treatment of ureteral injuries at the time of endourological
procedures are strongly related to a better outcome. Ureteral
perforation, avulsion or lost segment represent the rarest yet
dreaded occurrences [4, 31–35].
Clinical setting and indications for post-procedural
imaging
In most patients, clinical suspicion of early iatrogenic compli-
cations is based on a combination of intraoperative findings
with flank pain, persistent haematuria, fever, clinical or labo-
ratory evidence of blood loss and/or systemic inflammation
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hours or days after the procedure, prompting the urologic
surgeon to request urgent imaging. The majority of post-
procedural complications after ESWL and endourological
procedures are minor and result from urine infection or pas-
sage of small stone fragments along the ureter. However, since
pain, dysuria and transient haematuria are common
Fig. 1 Usual early post-procedural imaging appearances following ex-
tracorporeal shock wave lithotripsy (ESWL) in a 51-year-old male with a
12-mm stone in the left renal pelvis detected by preoperative unenhanced
multidetector CT (MDCT, A). Twenty-four hours after ESWL, repeat
MDCT (B, C) was requested because persistent flank pain showed a
ureteral stent in place, residual stone fragment in the lower pole calyx
(arrowhead in B), minimal perirenal fluid (*) and ipsilateral fascial
effusion (arrow in C), and thickened urothelium of the renal pelvis (thin
arrow in C). Afterwards, the patient experienced an uneventful postop-
erative course
Fig. 2 A 45-year-old female with
diabetes, antiretroviral-treated
human immunodeficiency virus
(HIV) infection and left partial
staghorn nephrolithiasis at
previous plain radiograph (A) and
MDCT urography (B) presented
9 weeks after percutaneous
nephrolithotomy (PCNL) with
clinical and contrast-enhanced
MDCT (C, D) evidence of
nephrocutaneous fistulisation






arrows) in the ureteropelvic
junction, proximal and mid-
ureter, and multiple residual stone





with permission from [51])
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complaints reported in up to 40 % of patients, diagnostic
imaging often proves crucial in the correct assessment of
treated patients, particularly to detect and quantify post-
procedural bleeding. As already mentioned, at some institu-
tions noncontrast MDCT is routinely obtained to assess the
post-procedural stone-free status. Post-treatment unenhanced
MDCT is extremely sensitive for detecting residual lithiasis
(Fig. 1) and commonly shows mild perirenal and fascial fluid
or blood that does not require treatment or prolonged
hospitalisation (Fig. 1). The characteristic “steinstrasse” ap-
pearance with calculi lining up along the ureter (Fig. 2) results
from stone fragmentation and distal migration and represents
an indication for URS. Furthermore, interpretation of
unenhanced MDCT provides important information
concerning possible complications, including excellent sensi-
tivity for detection of ipsilateral basal pleuropulmonary
changes, persistent hydronephrosis, fascial and paracolic gut-
ter fluid, and perinephric fluid or blood [3, 10, 27, 36].
With significant clinical, laboratory or unenhanced MDCT
findings, further investigation with iodinated contrast medium
(CM) is warranted unless contraindicated by renal failure.
Although ultrasound may rapidly detect most abnormal col-
lections, similarly to the trauma setting, enhanced multiphase
MDCTcomprehensively provides accurate detection and clas-
sification of iatrogenic lesions of the kidney and ureter, which
are crucial for optimal treatment choice and successful patient
management. After a preliminary unenhanced acquisition to
detect hyperattenuating blood, arterial-dominant and venous-
phase images after intravenous CM injection are recommend-
ed, particularly to identify CM extravasation indicating active
bleeding. Finally, excretory phase imaging obtained at least 5–
20 min later allows visualising the opacified collecting
Fig. 3 A 63-year-old male patient with comorbidities suffered from
syncope, flank pain and tenderness, with a 3 g/dl haemoglobin drop 6 h
after ESWL treatment of right-sided lithiasis of the renal pelvis
(arrowhead) and distal ureter (thin arrows) at preoperative unenhanced
MDCT (A). After bedside ultrasound (not shown) detected an
inhomogeneously echoic renal collection, urgent multiphase contrast-
enhanced MDCT including multiplanar reformatted images (B, C, D)
confirmed a hyperattenuating (55–60 HU) acute subcapsular renal
haematoma (*) extending towards the diaphragmatic crus. The ventrally
displaced right kidney appeared functioning with residual lithiasis and a
focal parenchymal laceration (thin arrow in D) in the nephrographic
acquisition. Atelectasis and moderate pleural effusion were seen at the
ipsilateral lung base. Hydronephrosis, active bleeding and urine extrava-
sation were excluded. Conservative treatment including blood transfu-
sions achieved clinical improvement and stabilisation of the haematocrit.
Follow-up MDCT 3 weeks later (E) showed haematoma (*) with de-
creased attenuation (35–40 HU) indicating initial liquefaction. One year
later, unenhanced MDCT during another episode of renal colic demon-
strated resolved haematoma (arrows in F)
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systems and detecting iodinated urine leaks and urinomas. In
order to limit the ionising radiation exposure in younger
patients, at most institutions classical multiphase MDCT is
being increasingly replaced by time- and dose-efficient split-
bolus acquisitions such as the triple-bolus MDCT urography
protocol, which provides simultaneous renovascular,
corticomedullary, nephrographic and excretory imaging. Fur-
thermore, repeated MDCT provides consistent monitoring of
injuries after conservative or interventional treatment [37–42].
Similarly to post-surgical injuries, iatrogenic trauma to the
ureter from endourological procedures is often (in almost two-
thirds of cases) undetected intraoperatively. Unfortunately,
delayed diagnosis is associated with a worse outcome due to
superinfection and renal damage. Clinically, ureteral injury
may be suggested by flank pain, urinary incontinence, vaginal
or drain urinary leakage, haematuria, fever, worsening renal
function, or imaging detection of hydronephrosis or urinoma
[5, 33, 34]. MDCT urography and—in selected patients—MR
urography represent the cross-sectional techniques of choice
to investigate suspected ureteral lesions noninvasively.
Unenhanced heavily T2-weighted MR sequences allow visu-
alisation of the static fluid content of the urinary tract, are most
useful with dilated or obstructed collecting systems, and may
be completed by means of gadolinium-enhanced excretory
MR urography as needed [43].
Cross-sectional imaging appearances of iatrogenic injuries
Haemorrhages
Minimal or moderate degrees of perinephric blood are ob-
served in approximately one-third of patients studied with
MDCT shortly after ESWL and PCNL, most usually
appearing as dense thickening of the perirenal septa (Fig. 1)
[27, 36]. Conversely, clinically significant iatrogenic
haematomas appear as hyperattenuating collections (45 to 90
Hounsfield Units, HU) on precontrast scans depending on
their more or less acute stage, being relatively hyperdense
compared to the renal parenchyma (Figs. 3, 4, 5 and 6). In
our experience, iatrogenic haematomas are most commonly or
initially subcapsular with the characteristic crescent- or
biconvex-shaped appearance limited by the renal capsule,
causing compression on the adjacent parenchyma, indenting
or flattening the renal margin. Haemorrhage extends variably
into the retroperitoneum, mostly by occupying the peri- and
pararenal spaces. Primarily perinephric haematomas are de-
marcated by the Gerota’s fascia and cause renal displacement.
Furthermore, focal parenchymal injuries closely similar to
traumatic lacerations may be observed as non-enhancing lin-
ear or irregular clefts (Figs. 3, 4 and 7). Heralded by linear or
flame-shaped high attenuation (85—370 HU) structures
Fig. 4 A 33-year-old female with nephrolithiasis and previous unsuc-
cessful ESWL treatment 3 years earlier underwent PCNL with ureteral
stenting. Preoperative unenhanced MDCT (A) showed the left kidney
with moderate pelvicalyceal dilatation, a 2-cm renal pelvis stone plus two
additional 8–9 mm lower calyx stones. Intractable flank and abdominal
pain with laboratory signs of blood loss (6.2 mg/dl nadir haemoglobin)
led to urgent contrast-enhanced multiphase MDCT hours after the proce-
dure. MDCT (B–F) detected a fresh clot in the left pelvicalyceal system
(thin arrows in B and F), thin subcapsular haematoma (arrows), massive
perirenal and posterior pararenal haemorrhage (*) causing anterior dis-
placement of spleen and kidney plus ureter medialisation (arrowheads).
A focal injury at the lower renal pole (thin arrow in E) corresponded to the
instrumentation access site, without signs of active bleeding and extrav-
asated urine. Urologists opted for conservative treatment including blood
transfusions. Seven days later, with improving clinical conditions, repeat
MDCT (G, H) showed retroperitoneal haemorrhage (*) with well-
demarcated margins and decreasing size, attenuation values and mass
effect (arrowhead in G)
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corresponding to CM extravasation, active bleeding at MDCT
indicates probable failure or nonsurgical management and
represents the strongest indication for interventional or surgi-
cal treatment. Furthermore, MDCT provides consistent
follow-up of conservatively treated lesions showing progres-
sive demarcation, size reduction and decreasing attenuation of
haematomas (Figs. 3, 4 and 6) [16, 39].
The majority of iatrogenic renal haematomas tend to reab-
sorb and can be successfully managed conservatively, includ-
ing appropriate transfusion support when signs of hypovole-
mic shock or haemoglobin decrease are present. Conversely,
angiographic embolisation or surgical exploration are re-
served for haematomas with MDCT evidence of ongoing
arterial bleeding and for those cases that do not respond
to a “watchful waiting” strategy. Required in less than
1 % of patients, superselective embolisation is the treat-
ment of choice and extremely effective in stopping
haemorrhage, with 100 % technical and 95 % clinical
success rates [5, 16, 28, 44, 45].
Most haematomas resolve within 2 years without adverse
effects on blood pressure and renal function. Persisting
liquefied haematomas may be amenable to percutaneous
drainage. Alternatively, the “Page kidney” phenomenon
consisting of long-term development of hypertension from
renal compression, ischaemia and hypoperfusion causing ac-
tivation of the renin-angiotensin-aldosterone system has been
reported [9, 46].
Furthermore, after PCNL, bleeding may occasionally
manifest as suburothelial haemorrhage (SH) of the renal
pelvis and ureter (Fig. 7). A very rare although well-
established condition, spontaneous SH most usually oc-
curs secondary to an excessive warfarin anticoagulant
therapy condition, sometimes with haemophilia or other
coagulation disorders. The characteristic CT appearance
includes a circumferential hyperattenuating mural thick-
ening of the renal pelvis, sometimes extending along the
proximal ureter, with an increased density that is often
subtle and better appreciable on unenhanced scans with
narrow window settings. On nephrographic images, the
mural thickening is less conspicuous and appears as
soft-tissue thickening, hypodense compared to opacified
urine in the collecting system. Despite encasement of
Fig. 5 A 55-year-old female with
a 12-mm calculus in the left pelvic
ureter (arrow in A) suffered fever
and anaemisation (7.8 g/dl
haemoglobin) 48 h after
ureteroscopic lithotripsy.
Unenhanced (B) and multiphase
contrast-enhanced (C, D) MDCT
detected a sizeable subcapsular
haematoma (*) causing moderate
parenchymal compression and
associated with blood effusion
along the ipsilateral fasciae (+),
without signs of active bleeding.
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the renal infundibulum, luminal compression and up-
stream calyceal dilatation are absent or minimal. In the
excretory phase small nodular filling defects or predom-
inantly smooth narrowing of the renal pelvis and ureter
are noted, so that misinterpretation as pyeloureteritis
cystica, pyonephrosis or transitional cell carcinoma
may occur. The usual fate is rapid, complete resolution
of imaging changes following conservative treatment
[47–49].
Severe urinary tract infections
Cross-sectional imaging signs of urinary infection are
mostly conspicuous in the nephrographic phase MDCT
acquisition. Infectious pyeloureteritis is heralded by
pelvicalyceal and/or ureteral thickening with prominent
urothelial enhancement (Figs. 2, 8 and 9). Because of
inflammatory debris obstructing the renal tubules and
impaired function from tubular ischaemia, acute pyelo-
nephri t is appears as a more or less enlarged,
oedematous kidney with decreased parenchymal en-
hancement (Fig. 8) or with the characteristic “striated
nephrogram” appearance including well-defined wedge-
shaped areas, linear bands or streaky zones of reduced
enhancement perpendicular to the cortical surface. Ac-
cessory signs such as perinephric fat stranding and
thickening of Gerota’s fascia are commonly observed
(Fig. 8). Progression of infection may lead to the for-
mation of variable-sized intra- or perirenal abscesses
(Fig. 9) with a characteristic appearance of round or
geographic hypoattenuating collections, usually surrounded
by a peripheral thickened enhancing capsule and by decreased
parenchymal enhancement corresponding to non-necrotic in-
fected kidney [50, 51].
Defined by an infected hydronephrosis, pyonephrosis rep-
resents a urological emergency that requires prompt interven-
tion to prevent sepsis and development of impaired renal
function. Radiologists should maintain a high level of suspi-
cion, since imaging differentiation of pyonephrosis from
hydronephrosis is challenging. Useful signs of an infected
collecting system include renal enlargement with a striated
or poorly functioning nephrogram, perinephric fat inflamma-
tory changes and urothelial thickening (Fig. 8). Occasionally
the obstructed cavities show higher-than-water (10–50 HU)
Fig. 6 A 66-year-old male
experienced severe flank pain
with acute blood loss shortly after
ureteroscopic stone removal.
Unenhanced (A), arterial (B) and
venous (C) phase MDCT images
showed large subcapsular renal
haematoma (*) with extensive
retroperitoneal bleeding including
the posterior pararenal space
(arrowheads), causing severe
parenchymal compression.
Contrast medium and urine
extravasation were excluded, thus
allowing conservative treatment.
A month later follow-up
unenhanced MDCT (D) with the
ureteral stent still in place showed
well-demarcated residual
haematoma with decreased size
and attenuation values (*)
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attenuation and/or fluid-fluid levels corresponding to purulent
urine. Decompression by means of nephrostomy or
ureteral stenting relieves obstruction and allows
confirming the diagnosis [50, 51].
Fig. 7 After PCNL treatment of a
2-cm left renal pelvis stone, a 46-
year-old female was not
discharged because of a
progressive, asymptomatic
haemoglobin drop (nadir 8.4 g/
dl). Four days later, unenhanced
MDCT showed a ureteral stent in
place, hyperattenuating (50 HU)
circumferential mural thickening
of the renal pelvis and proximal
ureter (thin arrows in A, B)
consistent with suburothelial
haemorrhage, and minimal blood
in the ipsilateral perirenal and
posterior pararenal spaces
(arrowhead in A). Study
completion with MDCT
urography showed a functioning
left kidney with a 2-cm
devascularised injury (arrow in C)
in the dorsal middle third and
hypodense suburothelial
haemorrhage (thin arrow in C, D)




discharge in a few days and
normalisation of the clinical,
biochemical and imaging
abnormalities within a month
Fig. 8 Three days after PCNL treatment, a 40-year-old female underwent
contrast-enhanced MDCT because of septic fever. Unenhanced (A) and
contrast-enhanced (B, C) images showed left-sided pelvicalyceal dilata-
tion with inflammatory-type stranding of the surrounding fat (*), mild
enhancing urothelial thickening (thin arrow in B), ipsilateral fascial
effusion (arrows) and decreased nephrographic parenchymal
enhancement compared to the contralateral kidney (C). Hydronephrosis
was due to small residual stone fragments in the lumbar ureter (not
shown). Clinical and imaging suspicion of pyonephrosis was confirmed
and relieved by positioning of the ureteral stent plus intensive antibiotic
therapy
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Ureteral injuries and urinomas
Major ureteral injuries with full-thickness mural involve-
ment are increasingly reported after ureteroscopic stone
removal (including RIRS) and occasionally PCNL, and
involve the proximal, middle and distal ureter in 51 %,
14 % and 35 % of cases, respectively. Resulting from
disruption of the urinary tract, iatrogenic urinomas
Fig. 9 A 38-year-old female with
intermittent fever and elevated C-
reactive protein 2 weeks after
PCNL treatment for right-sided
nephrolithiasis. Contrast-
enhancedMDCTwith the ureteral
stent in place showed absent
hydronephrosis, mild enhancing
ureteral thickening (thin arrows in
A, B) indicating infectious
pyeloureteritis and a 3-cm
hypoattenuating lesion with
peripheral delayed enhancement
(arrowheads in B and C) at the
lower renal pole consistent with
an abscess. The patient recovered
after intensive antibiotic
treatment. During follow-up,
distal stent migration was
detected radiographically (D)
Fig. 10 One day after PCNL treatment of right-sided urolithiasis,
unenhanced (A) and contrast-enhanced (B) MDCT obtained in a 75-year-
old female revealed mild uniform thickening of the pelvis (thin arrows)
consistent with suburothelial haemorrhage and/or inflammation, plus min-
imal posterior perirenal blood (arrowheads), which did not require therapy.
Two years later, a coronal MIP reformatted image from MDCT urography
(C), requested because of worsening renal function, showed persistent
dilatation of the renal pelvis due to iatrogenic stricture of the ureteropelvic
junction, with preserved parenchymal function and collecting system
opacification, which was treated with long-term nephrostomy
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represent abnormal collections of extravasated urine,
which may collect close to the site of the renal pelvis
or ureteral injury and otherwise variably dissect into the
retroperitoneum. Often clinically unsuspected but asso-
ciated with significant morbidity from superinfection,
iatrogenic urinomas are mostly treated by prolonged
nephrostomy or ureteral stenting [35, 37, 38].
Whereas in the past ureteral lacerations and urinomas
were usually depicted by means of trans-nephrostomy or
ascending pyelography, nowadays the diagnosis is usu-
ally made by MDCT. Urinomas commonly appear as
confined collections measuring 0–20 HU in unenhanced
scans and may be misinterpreted as ascites, abdominal
or pelvic abscesses, cystic masses or chronic liquefied
haematomas. The imaging hallmark of the urinoma is
represented by opacification (up to 80–200 HU) corre-
sponding to an enhanced urine leak observed on
excretory-phase or MDCT urography acquisitions.
Opacification is usually inhomogeneous in larger lesions
and usually progresses over repeated delayed-phase ac-
quisitions [37–40].
Resulting from previous minor (mucosal) injuries to
the urinary tract, late strictures predominantly occur at
the distal third of the ureter and are typically depicted
by MDCT or MR urography as a tight stricture with
upstream hydronephrosis (Fig. 10) or are benign-type
smooth tapering without an associated soft-tissue mass
(Fig. 11). Since retrograde stenting is frequently unsuc-
cessful, most ureteral injuries are treated by means of
nephrostomy with or without a ureteral catheter. Where-
as endourological repair of small ureteral fistulae and
strictures may be performed in selected cases, most
delayed occurrences need deferred reconstructive surgery
such as uretero-ureterostomy or uretero-neocystostomy to
preserve renal function [5, 33–35].
Conclusion
Due to the increasing prevalence of urolithiasis and the exten-
sive use of minimally invasive therapies, in hospitals with
Fig. 11 A 51-year-old male
received ureteroscopic removal of
a distal ureteral calculus
(ultrasound in A). Fifteen months
later, persistent upstream
hydronephrosis without evidence
of lithiasis at unenhanced MDCT
(not shown) led to performing
unenhanced magnetic resonance
(MR) urography. Pyelographic
(B) and axial T2-weighted images
showed smooth tapering of the
pelvic ureter (arrowheads),
without appreciable mural
thickening or extrinsic tissue at
the coronal T1-weighted image
(D), consistent with an iatrogenic
stricture
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active urologic practices early or delayed complications fol-
lowing ESWL, PCNL or URS are increasingly encountered.
Although uncommon, these occurrences should not be
underestimated since they can result in significant morbidity,
renal function impairment, occasional medico-legal litigation
and death. Appropriate patient selection with consideration of
possible contraindications, close monitoring of treated patients
for the development of post-procedural complications and
prompt use of MDCT imaging are highly recommended [4, 5].
In addition to identifying residual hydronephrosis and
stone fragments, unenhanced MDCT is highly useful to diag-
nose postoperative complications and could be potentially
considered in most treated patients [27, 36]. When patients’
complaints, physical examination, laboratory evidence of
blood loss or unenhanced MDCT findings suggest a signifi-
cant complication, prompt CM-enhanced MDCT investiga-
tion is warranted as the mainstay technique to provide a quick,
comprehensive assessment of renal and ureteral injuries.
MDCT consistently allows reliable detection and quantifica-
tion of retroperitoneal haemorrhage, differentiation from fluid
collections or extravasated urine and identification of active
bleeding, thus allowing an accurate assessment of the injury’s
severity, a correct therapeutic choice and reliable follow-up
during conservative treatment [37, 39].
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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